Contrast‑enhanced computerized tomography combined with a targeted nanoparticle contrast agent for screening for early‑phase non‑small cell lung cancer

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI

Background: Glucose transporter (Glut), a cellular transmembrane receptor, has a key role in the metabolism of cell glucose and is also associated with various human carcinomas.Objective: In this study, we evaluated a magnetic resonance (MR) imaging contrast agent for tumor detection based on paramagnetic gadolinium oxide (Gd2O3) coated polycyclodextrin (PCD) and mod...

Surgery for nonsmall cell lung cancer.

Surgery remains the best curative option in patients with early stage lung cancer (stage I and II). Developments in minimally invasive techniques now allow surgeons to perform lung resections on elderly patients, patients with poor pulmonary function or significant cardiopulmonary comorbidities. New techniques, such as stereotactic radiotherapy and ablative procedures, are being evaluated in ea...

Producing a Manual for the Multidetector-Row Computerized Tomography (MDCT) Imaging Method for Lung Cancer Screening

Application of novel targeting nanoparticles contrast agent combined with contrast-enhanced computed tomography during screening for early-phase gastric carcinoma

Gastric cancer is one of the most common human tumors worldwide. The biggest bottleneck is a lack of advanced and sensitive protocols for the diagnosis of patients with early-stage gastric cancer. Therefore, more sensitive methods of diagnosing gastric cancer are urgently required to improve survival rates. In this clinical study, contrast-enhanced computed tomography (CECT) with targeting nano...

Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations.

1 The respiratory health benefits of quitting cannabis use Donald P. Tashkin 5 Animal fur and asthma: an indoor farmyard phenomenon? Julian Crane 8 Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Bruce Culver 11 Cystic fibrosis in Europe: patients live longer but are we ready? Carsten Schwarz and Dominik Hartl 13 Never too old: beneficial neuro...